Carmen Swanepoel

Dr. Carmen Swanepoel


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 November 2013 in Biopreservation and Biobanking
Verified
Journal Article
Closed access
AAAkin Abayomi
Akin Abayomi
Alan ChristoffelsAlan Christoffels
Alan Christoffels
RGRavnit Grewal
Ravnit Grewal
LKLocunda A. Karam
Locunda A. Karam
CRCatherine Rossouw
Catherine Rossouw
BRBeverley van Rooyen
Beverley van Rooyen
The high burden of infectious diseases and the growing problem of noncommunicable and metabolic disease syndromes in South Africa (SA) forces a more focused research approach to facilitate cutting-edge scientific growth and public health development. Increased SA research on these diseases and syndromes and the collection of associated biospecimens has ensured a plethora of biobanks created by individuals, albeit without the foresight of prospective and collective use by other local and international researchers. As the need for access to high-quality specimens in statistically relevant numbers has increased, so has the necessity for the development of national human biobanks in SA and across the Continent. The prospects of achieving sustainable centralized biobanks are still an emerging and evolving concept, primarily and recently driven by the launch of the H3Africa consortium, which includes the development of harmonized and standardized biobanking operating procedures. This process is hindered by a myriad of complex societal considerations and ethico-legal challenges. Efforts to consolidate and standardize biological sample collections are further compromised by the lack of full appreciation by national stakeholders of the biological value inherent in these collections, and the availability of high quality human samples with well-annotated data for future scientific research and development. Inadequate or nonexistent legislative structures that specifically regulate the storage, use, dispersal, and disposal of human biological samples are common phenomena and pose further challenges. Furthermore, concerns relating to consent for unspecified future uses, as well as access to information and data protection, are all new paradigms that require further consideration and public engagement. This article reviews important fundamental issues such as governance, ethics, infrastructure, and bioinformatics that are important foundational prerequisites for the establishment and evolution of successful human biobanking in South Africa.

1 January 2020 in Journal of Law and the Biosciences
Verified
Journal Article
Open access
CSCiara Staunton
Ciara Staunton
CSCarmen Swanepoel
Carmen Swanepoel
MLMelodie Labuschaigne
Melodie Labuschaigne
The spread of COVID-19 across China, Asia, Europe and the United States of America was met with public health responses that initially encouraged hand washing and social distancing. They quickly turned to restrictions on the freedom of movement and assembly in the form of forced isolation, mandatory quarantines and lockdowns. Africa’s first confirmed case was not until 14 February in Egypt and March saw a steady spread of the virus throughout the African continent. Concern began to rise about the impact that the virus would have on a continent that is currently facing HIV and TB epidemics and sporadic outbreaks of Ebola and Lassa Fever. There were fears that the already weakened health systems in many African jurisdictions may be unable to cope with another pandemic and quick and decisive action to stop the spread of the virus was considered to be essential.

1 April 2017 in Biopreservation and Biobanking
Verified
Journal Article
Open access
HBHocine Bendou
Hocine Bendou
LSLunga Sizani
Lunga Sizani
TRTim Reid
Tim Reid
CSCarmen Swanepoel
Carmen Swanepoel
TAToluwaleke Ademuyiwa
Toluwaleke Ademuyiwa
Alan ChristoffelsAlan Christoffels
Alan Christoffels
A laboratory information management system (LIMS) is central to the informatics infrastructure that underlies biobanking activities. To date, a wide range of commercial and open-source LIMSs are available and the decision to opt for one LIMS over another is often influenced by the needs of the biobank clients and researchers, as well as available financial resources. The Baobab LIMS was developed by customizing the Bika LIMS software (www.bikalims.org) to meet the requirements of biobanking best practices. The need to implement biobank standard operation procedures as well as stimulate the use of standards for biobank data representation motivated the implementation of Baobab LIMS, an open-source LIMS for Biobanking. Baobab LIMS comprises modules for biospecimen kit assembly, shipping of biospecimen kits, storage management, analysis requests, reporting, and invoicing. The Baobab LIMS is based on the Plone web-content management framework. All the system requirements for Plone are applicable to Baobab LIMS, including the need for a server with at least 8 GB RAM and 120 GB hard disk space. Baobab LIMS is a server–client-based system, whereby the end user is able to access the system securely through the internet on a standard web browser, thereby eliminating the need for standalone installations on all machines.

1 May 2016
Verified
Conference Paper
Closed access
TKTomas Klingstrom
Tomas Klingstrom
MMMaimuna Mendy
Maimuna Mendy
DMDominique Meunier
Dominique Meunier
ABAnouk Berger
Anouk Berger
JRJane Reichel
Jane Reichel
HMHeimo Müller
Heimo Müller

1 April 2017 in Biopreservation and Biobanking
Verified
Journal Article
Open access
SKSamuel Kyobe
Samuel Kyobe
MHMusinguzi Henry
Musinguzi Henry
LNLwanga Newton
Lwanga Newton
KDKezimbira Dafala
Kezimbira Dafala
KEKigozi Edgar
Kigozi Edgar
SGSwartz Garth
Swartz Garth
Biorepositories in Africa need significant infrastructural support to meet International Society for Biological and Environmental Repositories (ISBER) Best Practices to support population-based genomics research. ISBER recommends a biorepository information management system which can manage workflows from biospecimen receipt to distribution. The H3Africa Initiative set out to develop regional African biorepositories where Uganda, Nigeria, and South Africa were successfully awarded grants to develop the state-of-the-art biorepositories. The biorepositories carried out an elaborate process to evaluate and choose a laboratory information management system (LIMS) with the aim of integrating the three geographically distinct sites. In this article, we review the processes, African experience, lessons learned, and make recommendations for choosing a biorepository LIMS in the African context.

28 July 2015 in Critical Reviews in Clinical Laboratory Sciences
Verified
Journal Article
Closed access
PDF file
RGRavnit Grewal
Ravnit Grewal
ACAndrei Cucuianu
Andrei Cucuianu
CSCarmen Swanepoel
Carmen Swanepoel
DDDelia Dima
Delia Dima
BPBobe Petrushev
Bobe Petrushev
CTCiprian Tomuleasa
Ciprian Tomuleasa
The incidence of HIV-related lymphomas (HRLs) is increased by 60–100 times in patients with HIV. When compared to the general population, patients with HRLs often present with extranodal lymphoid proliferation, most frequently of the gastrointestinal tract, central nervous system, liver and bone marrow. MicroRNAs (miRs) are non-coding double-stranded RNA molecules of 18–25 nucleotides that regulate post-translational gene expression by inhibiting translation or promoting degradation of messenger RNA complementary sequences. Before their discovery, tumorigenesis was thought to have been caused by the alteration of protein-coding oncogenes and tumor-suppressor genes, but once identified in B-cell chronic lymphocytic leukemia, miRs function as either oncogenes or tumor-suppressor genes was confirmed in different types of malignancies. Since miRs are clearly involved in tumorigenesis in many cancers, their role in HRLs is now receiving attention. A few studies have been conducted thus far in some HRLs on the involvement of miR in the pathogenesis of lymphoid malignancies. Since B-cell lymphomas arise from various stages of B-cell development in both HIV-infected and HIV-naïve patients, investigators have tried to determine the different miR signatures in B-cell development. As classic immunohistochemistry staining is sometimes not enough for the differential diagnosis of HRLs, in the present review, we have described the potential use of miRs in the prognosis and diagnosis of these diseases.